Page last updated: 2024-08-21

indazoles and Leukemia, Pre-B-Cell

indazoles has been researched along with Leukemia, Pre-B-Cell in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Accordi, B; Basso, G; Bresolin, S; Cortese, G; Mariotto, E; Porcù, E; Serafin, V; Veltri, G	1
Becker, A; Chabanovska, O; Junghanss, C; Murua Escobar, H; Ngezahayo, A; Sekora, A; Sender, S; Villa Perez, S	1

Other Studies

2 other study(ies) available for indazoles and Leukemia, Pre-B-Cell

Article	Year
SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric International journal of molecular sciences, 2019, Dec-07, Volume: 20, Issue:24 Topics: Aminopyridines; Cell Proliferation; Child; Core Binding Factor Alpha 2 Subunit; Cyclohexylamines; Drug Resistance, Neoplasm; Humans; Indazoles; Morpholines; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Oxazines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrazines; Pyridines; Pyrimidines; Syk Kinase; Tumor Cells, Cultured	2019
Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib. International journal of molecular sciences, 2021, Jan-08, Volume: 22, Issue:2 Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Gene Expression Regulation, Leukemic; Humans; Indazoles; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cells, B-Lymphoid; Pyrazines; Sequence Analysis, RNA; Syk Kinase	2021

Article

Year

SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric

International journal of molecular sciences, 2019, Dec-07, Volume: 20, Issue:24

Topics: Aminopyridines; Cell Proliferation; Child; Core Binding Factor Alpha 2 Subunit; Cyclohexylamines; Drug Resistance, Neoplasm; Humans; Indazoles; Morpholines; Neoplasm Recurrence, Local; Oncogene Proteins, Fusion; Oxazines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrazines; Pyridines; Pyrimidines; Syk Kinase; Tumor Cells, Cultured

2019

Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib.

International journal of molecular sciences, 2021, Jan-08, Volume: 22, Issue:2

Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Gene Expression Regulation, Leukemic; Humans; Indazoles; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cells, B-Lymphoid; Pyrazines; Sequence Analysis, RNA; Syk Kinase

2021